---
title: "Metsera (MTSR.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MTSR.US.md"
symbol: "MTSR.US"
name: "Metsera"
industry: "Biotechnology"
datetime: "2026-03-03T13:29:41.309Z"
locales:
  - [en](https://longbridge.com/en/quote/MTSR.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MTSR.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MTSR.US.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MTSR.US.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MTSR.US.md)


# Metsera (MTSR.US)

## Company Overview

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -23.60 | 546 | - | - | - |
| PB | 22.00 | 424 | 22.00 | 12.30 | 7.11 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 70.50 |
| Highest Target | 57.00 |
| Lowest Target | 57.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/MTSR.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/MTSR.US/norm.md)
- [Related News](https://longbridge.com/en/quote/MTSR.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/MTSR.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**